Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning. [PDF]
Liu Q +9 more
europepmc +1 more source
Erratum: Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice. [PDF]
Kim KE +12 more
europepmc +1 more source
CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma. [PDF]
Yang L +7 more
europepmc +1 more source
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis.
Abdel-Samiee M +4 more
europepmc +1 more source
The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. [PDF]
Miao Y +6 more
europepmc +1 more source
2. Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalchoholic Steatohepatitis (NASH)
S. Ohnishi, T. Saibara
openalex +2 more sources
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis. [PDF]
Joo JY, Yoo IH, Yang HR.
europepmc +1 more source
Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index. [PDF]
Kim S, Yoo HY.
europepmc +1 more source

